throbber
Paper No. 17
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`_____________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`MICRO LABS LIMITED AND MICRO LABS USA INC.
`Petitioners,
`
`v.
`
`SANTEN PHARMACEUTICAL CO., LTD. AND ASAHI GLASS CO., LTD.
`Patent Owners.
`_____________
`
`Inter Partes Review No. IPR2017-01434
`U.S. Patent No. 5,886,035
`
`_____________
`
`
`MOTION FOR PRO HAC VICE ADMISSION OF H. KEETO
`SABHARWAL UNDER 37 C.F.R. § 42.10(c)
`
`
`
`
`
`
`
`
`
`
`
`

`

`I.
`
`RELIEF REQUESTED
`Pursuant to 37 C.F.R. § 42.10(c), Petitioners Micro Labs USA Inc. and
`
`Micro Labs Limited (together, "Petitioners") respectfully request the pro hac vice
`
`admission of H. Keeto Sabharwal in this proceeding.
`
`II.
`
`STATEMENT OF FACTS
`Based on the following facts, and supported by the Declaration of Mr.
`
`Sabharwal (Ex. 1) submitted herewith, Petitioners request the pro hac vice
`
`admission of H. Keeto Sabharwal in this proceeding:
`
`1.
`
`Petitioner's lead counsel, Cedric C.Y. Tan, is a registered practitioner.
`
`2. Mr. Sabharwal is a partner at the law firm of Pillsbury Winthrop Shaw
`
`Pittman LLP.
`
`3. Mr. Sabharwal is an experienced patent litigation attorney and Mr.
`
`Sabharwal has been a patent litigation attorney for over 20 years. (Ex. 1 at ¶ 1.)
`
`Mr. Sabharwal has been litigating patent cases during this entire time period and,
`
`in particular, has litigated at least 25+ patent infringement actions involving a
`
`variety of pharmaceutical and life sciences technologies, and has served as lead
`
`trial counsel in a large majority of these matters. (Id.)
`
`4. Mr. Sabharwal has reviewed in detail the pleadings submitted by
`
`Petitioner and Patent Owner in this proceeding. (Id. at ¶ 7.) And Mr. Sabharwal has
`
`reviewed in detail the challenged patent, U.S. Patent No. 5,886,035 (“the '035
`
`2
`
`

`

`patent”). (Id.) He has also reviewed in detail the relevant references, pleadings and
`
`arguments set forth by both Petitioner and Patent Owner in this proceeding. (Id.)
`
`5. Mr. Sabharwal has engaged in hours of strategic and substantive
`
`discussions regarding this proceeding with Cedric C.Y. Tan, who serves as lead
`
`counsel respectively for Petitioner in this proceeding. (Id. at ¶ 8.) Mr. Sabharwal
`
`was an integral part of the strategic planning and preparation of the Petition for
`
`Inter Partes Review which initiated this proceeding. (Id.) Mr. Sabharwal was
`
`involved in all aspects of the Petition for Inter Partes Review, including drafting
`
`and revising the Petition and the accompanying declarations in support of the
`
`Petition. Mr. Sabharwal is very familiar with all aspects of this proceeding
`
`including Petitioner's factual investigation and development of its unpatentability
`
`positions regarding the challenged claims of the '035 patent. (Id.)
`
`6. Mr. Sabharwal has also been the lead trial counsel for the Petitioner in
`
`district court litigations, including Santen Pharmaceutical Co., Ltd. et al. v. Micro
`
`Labs Ltd. et al., C.A. No. 16-353 (GMS) (D. Del.) which involves the '035 patent.
`
`(Id. at ¶ 9.) Mr. Sabharwal will continue to serve as lead litigation counsel for
`
`Petitioner in this litigation. (Id.)
`
`7. Mr. Sabharwal is a member of good standing of the State Bar of New
`
`York and the Bar of the District of Columbia. (Id. at ¶ 3.)
`
`3
`
`

`

`8. Mr. Sabharwal has never been suspended or disbarred from practice
`
`before any court or administrative body. (Id. at ¶ 4.)
`
`9.
`
`No application of Mr. Sabharwal for admission to practice before any
`
`court or administrative body has ever been ultimately denied.1 (Id. at ¶ 5.)
`
`10. No sanctions or contempt citations have ever been imposed against
`
`Mr. Sabharwal by any court or administrative body. (Id. at ¶ 6.)
`
`11. Mr. Sabharwal has read and will comply with the Office Patent Trial
`
`Practice Guide and the Board’s Rules of Practice for Trials set forth in part 42 of
`
`the C.F.R. (Id. at ¶ 10.)
`
`
`1 The Board initially denied Mr. Sabharwal pro hac vice admission without
`
`prejudice and with permission to re-file in Cases IPR2012-00022 and IPR2013-
`
`00250 because the moving papers did not fully articulate his familiarity with the
`
`subject matter at issue in those proceedings. Both proceedings concerned a single
`
`patent at issue. (See Case IPR2012-00022, Paper 53; Case IPR2013-00250, Paper
`
`21.) After providing additional detail showing Mr. Sabharwal's familiarity with the
`
`subject matter at issue in the proceedings, the Board granted Mr. Sabharwal pro
`
`hac vice admission in both cases. (Id.)
`
`4
`
`

`

`12. Mr. Sabharwal understands that he will be subject to the USPTO Code
`
`of Professional Responsibility set forth in 37 C.F.R. §§ 10.20 et seq. and
`
`disciplinary jurisdiction under 37 C.F.R. § 11.19(a). (Id. at ¶ 11.)
`
`13. Mr. Sabharwal has applied to appear pro hac vice in the following
`
`proceeding before the Office in the last three (3) years: Case IPR2014-00876. (Id.
`
`at ¶ 12.)
`
`III. GOOD CAUSE EXISTS FOR PRO HAC VICE ADMISSION
`The Board may recognize counsel pro hac vice during a proceeding upon a
`
`showing of good cause, subject to the condition that lead counsel be a registered
`
`practitioner and to any other conditions as the Board may impose. 37 C.F.R. §
`
`42.10(c). Petitioner's lead counsel, Cedric C.Y. Tan, is a registered practitioner.
`
`Based on the facts contained herein, as supported by Mr. Sabharwal's Declaration,
`
`good cause exists to admit Mr. Sabharwal pro hac vice in this proceeding because
`
`Mr. Sabharwal has an established familiarity with the subject matter at issue in this
`
`proceeding. (Ex. 1 at ¶¶ 7-9.) Additionally, Mr. Sabharwal's pro hac vice
`
`admission would serve to provide Petitioner with the counsel of its choice, will
`
`better align administration of the IPR with potential district court litigation, and is
`
`essential to settlement efforts between Patent Owner and Petitioner. Based on the
`
`facts contained herein, as supported by Mr. Sabharwal’s Affidavit, good cause
`
`exists to admit Mr. Sabharwal pro hac vice in this proceeding.
`
`5
`
`

`

`
`
`IV. CONCLUSION
`For the foregoing reasons, Petitioner respectfully requests that Mr.
`
`Sabharwal be admitted pro hac vice in this proceeding. This Motion for Pro Hac
`
`Vice Admission is accompanied by a Declaration of H. Keeto Sabharwal (Exhibit
`
`1).
`
`
`
`Dated: January 3, 2018
`
`
`
`
`
`By: /Cedric C.Y. Tan/
` Cedric C.Y. Tan (Reg. No. 56,082)
`PILLSBURY WINTHROP
`SHAW PITTMAN LLP
`1200 Seventeenth Street, NW
`Washington, DC 20036
`Tel.: (202) 663-8000
`Fax.: (202) 663-8007
`Email: cedric.tan@pillsburylaw.com
`
`
`6
`
`

`

`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`MICRO LABS LIMITED AND MICRO LABS USA INC.
`Petitioners,
`
`v.
`
`SANTEN PHARMACEUTICAL CO., LTD. AND ASAHI GLASS CO., LTD.
`Patent Owners.
`_____________
`
`Inter Partes Review No. IPR2017-01434
`U.S. Patent No. 5,886,035
`
`
`
`DECLARATION OF H. KEETO SABHARWAL IN SUPPORT OF
`PETITIONER’S MOTION FOR PRO HAC VICE
`ADMISSION OF H. KEETO SABHARWAL
`
`
`
`
`
`
`
`
`

`

`I, H. Keeto Sabharwal, declare as follows:
`
`1.
`
`I am an experienced litigating attorney with more than twenty (20)
`
`years of experience.
`
`2.
`
`I have been litigating patent cases during that entire time. I served as
`
`lead trial counsel in a large majority of these patent cases. Most of the
`
`patent cases in which I served as lead trial counsel involved
`
`pharmaceutical products. I have litigated at least 25+ patent
`
`infringement actions involving a variety of pharmaceutical and life
`
`science technologies.
`
`3.
`
`I am a member in good standing of State Bar of New York and the
`
`Bar of the District of Columbia.
`
`4.
`
`I have never been suspended or disbarred from practice before any
`
`court or administrative body.
`
`5.
`
`I have never been ultimately denied admission to practice before any
`
`court or administrative body. I was temporarily denied pro hac vice
`
`admission without prejudice and with permission to re-file in a single
`
`instance by the PTAB in Cases IPR2012-00022 and IPR2013-00250
`
`because the moving papers did not fully articulate my familiarity with
`
`the subject matter at issue in the proceedings. After I provided
`
`additional detail showing my familiarity with the subject matter at
`
`2
`
`

`

`issue in those proceedings, the Board granted my pro hac vice
`
`admission in both cases. See Case IPR2012-00022, Paper 53; Case
`
`IPR2013-00250, Paper 21.
`
`6.
`
`I have had no sanctions or contempt citations imposed against me by
`
`any court or administrative body.
`
`7.
`
`I have an established familiarity with the subject matter at issue in this
`
`proceeding. I have reviewed in detail U.S. Patent No. 5,886,035 ("the
`
`'035 patent"), which is the patent challenged in this proceeding. I have
`
`also reviewed the Exhibits submitted by Petitioner in this proceeding.
`
`8.
`
`I have engaged in hours of strategic and substantive discussions
`
`regarding this proceeding with Cedric C.Y. Tan, who serves as lead
`
`counsel respectively for Petitioner in this proceeding. I was an integral
`
`part of the strategic planning and preparation of the Petition for Inter
`
`Partes Review which initiated this proceeding. I was involved in all
`
`aspects of this petition, including drafting and revising the Petition
`
`and the accompanying declarations in support of the Petition. I am
`
`very familiar with all aspects of this proceeding including Petitioner's
`
`factual investigation and development of its unpatentability positions
`
`regarding the challenged claims of the '035 patent.
`
`3
`
`

`

`9.
`
`I have also been the lead trial counsel for the Petitioner in district
`
`court litigations including Santen Pharmaceuticals, et al. v. Micro
`
`Labs Ltd., et al, C.A. No. 16-353 (GMS) (Consolidated) (D. Del.)
`
`which involves the '035 patent. I will continue to serve as lead
`
`litigation counsel for Petitioner in this litigation.
`
`10.
`
`I have read and will comply with the Office Patent Trial Practice
`
`Guide and the Board’s Rules of Practice for Trials set forth in part 42
`
`of the Code of Federal Regulations.
`
`11.
`
`I agree to be subject to the USPTO Code of Professional
`
`Responsibility set forth in 37 C.F.R. §§10.20 et seq., and to
`
`disciplinary jurisdiction under 37 C.F.R. §11.19(a).
`
`12.
`
`I have applied to appear pro hac vice in the following proceeding
`
`before the Office in the last three (3) years: Case IPR2014-00876.
`
`13.
`
`I hereby declare that all statements made herein of my own
`
`knowledge are true and that all statements made on information and
`
`belief are believed to be true; and further that these statements are
`
`made with the knowledge that willful false statements and the like so
`
`made are punishable by fine or imprisonment, or both, under Section
`
`1001 of Title 18 of the United States Code and that such willful false
`
`statements may jeopardize the validity of U.S. Patent No. 5,886,035.
`
`4
`
`

`

`
`
`
`
`Dated: January 3, 2018
`
`
`
`By: /H. Keeto Sabharwal/
` H. Keeto Sabharwal
`
`5
`
`

`

`
`
`CERTIFICATE OF SERVICE
`Pursuant to 37 C.F.R. § 42.6(e), the undersigned certifies that a copy of the
`
`foregoing Motion for Pro Hac Vice Admission of H. Keeto Sabharwal Under 37
`
`C.F.R. § 42.10(c) and a copy of Declaration of H. Keeto Sabharwal in Support of
`
`Petitioner’s Motion for Pro Hac Vice Admission were served on January 3, 2018,
`
`by filing this document through the Patent Trial and Appeal Board End to End
`
`System as well as delivering a copy via electronic mail upon the following attorneys
`
`of record for the Patent Owners:
`
`Arlene L. Chow (Reg. No. 47,489)
`arlene.chow@hoganlovells.com
`Eric J. Lobenfeld (pro hac vice)
`eric.lobenfeld@hoganlovells.com
`Ernest Yakob, Ph.D. (Reg. No. 45,893)
`ernest.yakob@hoganlovells.com
`HOGAN LOVELLS US LLP
`875 Third Avenue
`New York, NY 10022
`Tel: (212) 918-3000
`Fax: (212) 918-3100
`
`
`
` /Cedric C.Y. Tan/
` Cedric C.Y. Tan (Reg. No. 56,082)
`PILLSBURY WINTHROP
`SHAW PITTMAN LLP
`1200 Seventeenth Street, NW
`Washington, DC 20036
`Tel.: (202) 663-8000
`Fax.: (202) 663-8007
`Email: cedric.tan@pillsburylaw.com
`
`
`
`
`
`
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket